NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) (PA-25-080)

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) (PA-25-080) is sponsored by NIH. This program supports conferences and scientific meetings. Universities in psychosocial oncology can apply to host conferences to disseminate research, foster collaborations, and advance the field.

PA-25-080: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission. Department of Health and Human Services Part 1.

Overview Information Participating Organization(s) National Institutes of Health ( NIH ) Components of Participating Organizations NATIONAL INSTITUTES OF HEALTH ( NIH ) National Eye Institute ( NEI ) National Human Genome Research Institute ( NHGRI ) National Institute of Allergy and Infectious Diseases ( NIAID ) National Institute of Arthritis and Musculoskeletal and Skin Diseases ( NIAMS ) National Institute of General Medical Sciences ( NIGMS ) National Institute of Neurological Disorders and National Library of Medicine ( NLM ) National Center for Complementary and Integrative Health ( NCCIH ) National Center for Advancing Translational Sciences ( NCATS ) Office of Strategic Coordination ( Common Fund ) National Heart, Lung, and Blood Institute ( NHLBI ), October 04, 2024 - Participation added ( NOT-HL-24-033 ) National Institute of Dental and Craniofacial Research ( NIDCR ), October 07, 2024 - Participation added ( NOT-DE-25-041 ) National Institute on Alcohol Abuse and Alcoholism ( NIAAA ), October 07, 2024 - Participation added ( NOT-AA-24-016 ) Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD ), October 07, 2024 - Participation added ( NOT-HD-24-040 ) National Institute on Diabetes and Digestive and Kidney Diseases ( NIDDK ), October 08, 2024 - Participation added ( NOT-DK-25-003 ) National Institute on Deafness and Other Communication Disorders ( NIDCD ), October 09, 2024 - Participation added ( NOT-DC-25-004 ) National Cancer Institute ( NCI ), October 10, 2024 - Participation added ( NOT-CA-24-110 ) National Institute of Biomedical Imaging and Bioengineering ( NIBIB ), October 10, 2024 - Participation added ( NOT-EB-24-015 ) National Institute on Aging ( NIA ), October 11, 2024 - Participation added ( NOT-AG-24-065 ) National Institute of Nursing Research ( NINR ), October 16, 2024 - Participation added ( NOT-NR-25-002 ) National Institute on Drug Abuse ( NIDA ), October 16, 2024 - Participation added ( NOT-DA-24-050 ) National Institute of Environmental Health Sciences ( NIEHS ), October 18, 2024 - Participation added ( NOT-ES-25-001 ) National Institute on Minority Health and Health Disparities ( NIMHD ), November 12, 2024 - Participation added ( NOT-MD-25-003 ) National Institute of Environmental Health Sciences Superfund Research Program ( SRP ), November 18, 2025 - Participation added ( NOT-ES-25-007 ) Office of Research Infrastructure Programs ( ORIP ), June 4, 2025 - Participation added ( NOT-OD-25-067 ) Office of Research on Women's Health ( ORWH ), June 4, 2025 - Participation added ( NOT-OD-25-120 ) National Institute of Mental Health ( NIMH ), July 14, 2026 - Participation added ( NOT-MH-26-045 ) Note: Not all NIH Institutes, Centers, and Offices (ICOs) participate in Announcements.

Applicants should carefully note which ICOs participate in this announcement and view their respective areas of research interest at the ICO-Specific Scientific Interests website . ICOs that do not participate in this announcement will not consider applications for funding.

Funding Opportunity Title NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) R13 Support for Conferences and Scientific Meetings Notices of Special Interest associated with this funding opportunity July 14, 2026 - Notice of NIMH Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-MH-26-045 .

February 10, 2026 - NIH No Longer Requires Advanced Permission for Conference Grant Applications. See Notice NOT-OD-26-040 . January 28, 2026 - NIH Removing AIDS Application Due Dates from NOFOs.

See Notice NOT-OD-26-029. November 18, 2025 - Notice of NIEHS Superfund Research Program Participation in NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See Notice NOT-ES-25-007 .

June 9, 2025 - Notice of NIMH Withdrawal from Participation in PA-25-080, "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-MH-25-210 . June 5, 2025 - Notice of ORWH's Participation in PA-25-080 NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) .

See Notice NOT-OD-25-120 . June 4, 2025 - Notice of ORIP Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-OD-25-067 .

March 31, 2025 - This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission. November 12, 2024 - Notice of Participation of NIMHD in PA-25-080.

See Notice NOT-MD-25-003 . October 18, 2024 - NIEHS Notice of Participation in PA-25-080 "Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not allowed)". See Notice NOT-ES-25-001 .

October 16, 2024 - Notice of NIDA Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-DA-24-050 . October 16, 2024 - Notice of Participation of the National Institute of Nursing Research (NINR) in PA-25-080, "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)".

See Notice NOT-NR-25-002 . October 11, 2024 - Notice of Participation of the National Institute on Aging in PA-25-080, "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-AG-24-065 .

October 10, 2024 - Notice of NIBIB Participation in PA-25-080: "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-EB-24-015 . October 10, 2024 - Notice of NIMH Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed).

See Notice NOT-MH-25-035 . October 10, 2024 - Notice of Participation of National Cancer Institute in PA-25-080: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See Notice NOT-CA-24-110 .

October 09, 2024 - Notice of NIDCD Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-DC-25-004 . October 08, 2024 - Notice of NIDDK Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)".

See Notice NOT-DK-25-003 . October 07, 2024 - Notice of NICHD Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-HD-24-040 .

October 07, 2024 - Notice of NIAAA Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)". See Notice NOT-AA-24-016 . October 07, 2024 - NIDCR Notice of Participation in PA-25-080 "NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)".

See Notice NOT-DE-25-041 . October 04, 2024 - Notice of NHLBI Participation in PA-25-080: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed). See Notice NOT-HL-24-033 .

April 04, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25, 2025. See Notice NOT-OD-24-084 . August 31, 2022 - Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023.

See Notice NOT-OD-22-198 . August 5, 2022 - Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189 .

Funding Opportunity Number (FON) Companion Funding Opportunity See Section III. 3. Additional Information on Eligibility .

Assistance Listing Number(s) 93. 853, 93. 855, 93.

310, 93. 350, 93. 859, 93.

213, 93. 867, 93. 172, 93.

879, 93. 846, 93. 837, 93.

838, 93. 839, 93. 840, 93.

233, 93. 121, 93. 273, 93.

865, 93. 847, 93. 173, 93.

393, 93. 394, 93. 395, 93.

396, 93. 399, 93. 286, 93.

866, 93. 361, 93. 279, 93.

113, 93. 307, 93. 351, 93.

313, 93. 143,93. 242 Funding Opportunity Purpose The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

Open Date (Earliest Submission Date) The following table includes NIH standard due dates marked with an asterisk. Renewal / Resubmission / Revision (as allowed) AIDS - New/Renewal/Resubmission/Revision, as allowed All applications are due by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Required Application Instructions It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide , except where instructed to do otherwise (in this NOFO or in a Notice from NIH Guide for Grants and Contracts ). Conformance to all requirements (both in the How to Apply - Application Guide and the NOFO) is required and strictly enforced.

Applicants must read and follow all application instructions in the How to Apply - Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the How to Apply - Application Guide , follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

There are several options available to submit your application through Grants. gov to NIH and Department of Health and Human Services partners. You must use one of these submission options to access the application forms for this opportunity.

Use the NIH ASSIST system to prepare, submit and track your application online. Use an institutional system-to-system (S2S) solution to prepare and submit your application to Grants. gov and eRA Commons to track your application.

Check with your institutional officials regarding availability. Workspace to prepare and submit your application and eRA Commons to track your application. Part 1.

Overview Information Part 2. Full Text of Announcement Section I. Notice of Funding Opportunity Description Section II.

Award Information Section III. Eligibility Information Section IV. Application and Submission Information Section V.

Application Review Information Section VI. Award Administration Information Section VII. Agency Contacts Section VIII.

Other Information Part 2. Full Text of Announcement Section I. Notice of Funding Opportunity Description The purpose of the NIH Research Conference Grant (R13) is to support high quality scientific conferences that are relevant to the NIH's mission and to the public health.

A conference is defined as a symposium, seminar, workshop, or any other organized and formal meeting, whether conducted face-to-face or via the internet, where individuals assemble (or meet virtually) for the primary purpose to exchange technical information and views or explore or clarify a defined subject, problem, or area of knowledge, whether or not a published report results from such meeting.

The NIH recognizes the value to members of the research community and all other interested parties in supporting such forums. Support of conferences is contingent on the fiscal and programmatic interests and priorities of the individual NIH Institutes and Centers (ICs). The website, NIH Support for Conferences and Scientific Meetings ,centralizes information regarding grants for scientific conferences.

The Contacts and Special Interests section of that website includes contact information for the participating ICs as well as information about each IC's specific interests and funding parameters. Note: Applicants are encouraged to look at the R13 Frequently Asked Questions for a listing of common questions regarding the preparation and submission of conference grant applications. See Section VIII.

Other Information for award authorities and regulations. Section II. Award Information Grant: A financial assistance mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.

Application Types Allowed The OER Glossary and the How to Apply - Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO. Not Allowed: Only accepting applications that do not propose clinical trials.

Need help determining whether you are doing a clinical trial? Funds Available and Anticipated Number of Awards The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. Application budgets are not limited but need to reflect the actual needs of the proposed project.

The appropriate NIH Conference Grant Contact should be consulted for guidance regarding any IC-specific budget limitations. Most ICs will accept applications for up to 5 years of support when a series of annual or biannual conferences are proposed by a permanently sponsoring organization. Support for conferences held on a less frequent schedule must be applied for individually.

The appropriate NIH Conference Grant Contact should be consulted for guidance regarding any IC-specific project duration requirement. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO. Section III.

Eligibility Information Higher Education Institutions Public/State Controlled Institutions of Higher Education Private Institutions of Higher Education Nonprofits Other Than Institutions of Higher Education Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) For-Profit Organizations (Other than Small Businesses) City or Township Governments Special District Governments Indian/Native American Tribal Governments (Federally Recognized) Indian/Native American Tribal Governments (Other than Federally Recognized) Eligible Agencies of the Federal Government U.S. Territory or Possession Independent School Districts Public Housing Authorities/Indian Housing Authorities Native American Tribal Organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Domestic institutions or organizations, including established scientific or professional societies, are eligible to apply for conference support.

Foreign organizations are not eligible to apply for conference support. Both domestic and international conferences may be supported; however, an international conference can be supported only through the U.S. representative organization of an established international scientific or professional society. An individual is not eligible to receive a grant in support of a conference.

Foreign Organizations/Foreign Collaborations Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement , are allowed.

NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. This new requirement was effective, May 1, 2025.

Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding.

This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components , funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Applicant organizations must complete and maintain the following registrations as described in the How to Apply - Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible.

Failure to complete registrations in advance of a due date is not a valid reason for a late submission, please reference NIH Grants Policy Statement Section 2. 3. 9.

2 Electronically Submitted Applications for additional information System for Award Management (SAM) – Applicants must complete and maintain an active registration, which requires renewal at least annually . The renewal process may require as much time as the initial registration.

SAM registration includes the assignment of a Commercial and Government Entity (CAGE) Code for domestic organizations which have not already been assigned a CAGE Code. NATO Commercial and Government Entity (NCAGE) Code – Foreign organizations must obtain an NCAGE code (in lieu of a CAGE code) in order to register in SAM. Unique Entity Identifier (UEI) - A UEI is issued as part of the SAM.

gov registration process. The same UEI must be used for all registrations, as well as on the grant application. eRA Commons - Once the unique organization identifier is established, organizations can register with eRA Commons in tandem with completing their Grants.

gov registrations; all registrations must be in place by time of submission. eRA Commons requires organizations to identify at least one Signing Official (SO) and at least one Program Director/Principal Investigator (PD/PI) account in order to submit an application. Grants.

gov – Applicants must have an active SAM registration in order to complete the Grants. gov registration. Program Directors/Principal Investigators (PD(s)/PI(s)) All PD(s)/PI(s) must have an eRA Commons account.

PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.

All PD(s)/PI(s) must be registered with ORCID . The personal profile associated with the PD(s)/PI(s) eRA Commons account must be linked to a valid ORCID ID. For more information on linking an ORCID ID to an eRA Commons personal profile see the ORCID topic in our eRA Commons online help .

Eligible Individuals (Program Director/Principal Investigator) Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with their organization to develop an application for support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the How to Apply - Application Guide . This NOFO does not require cost sharing as defined in the NIH Grants Policy Statement NIH Grants Policy Statement Section 1. 2 Definition of Terms.

3. Additional Information on Eligibility Applicant organizations may submit more than one application, provided that each application is scientifically distinct. The NIH will not accept duplicate or highly overlapping applications under review at the same time, per NIH Grants Policy Statement Section 2.

3. 7. 4 Submission of Resubmission Application .

This means that the NIH will not accept: A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application. A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.

An application that has substantial overlap with another application pending appeal of initial peer review (see NIH Grants Policy Statement 2. 3. 9.

4 Similar, Essentially Identical, or Identical Applications ). Section IV. Application and Submission Information 1.

Requesting an Application Package The application forms package specific to this opportunity must be accessed through ASSIST, Grants. gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.

gov Workspace are available in Part 1 of this NOFO. See your administrative office for instructions if you plan to use an institutional system-to-system solution. 2.

Content and Form of Application Submission It is critical that applicants follow the instructions in the Research (R) Instructions in the How to Apply - Application Guide except where instructed in this notice of funding opportunity to do otherwise. Conformance to the requirements in the How to Apply - Application Guide is required and strictly enforced.

Applications that are out of compliance with these instructions may be delayed or not accepted for review. For information on Application Submission and Receipt, visit Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications . All page limitations described in the How to Apply – Application Guide and the Table of Page Limits must be followed.

Instructions for Application Submission The following section supplements the instructions found in the How to Apply – Application Guide and should be used for preparing an application to this NOFO. All instructions in the How to Apply - Application Guide must be followed. Descriptive Title of Applicant's Project: Enter the title of the scientific conference.

Cover Letter: Advance permission to submit an application is required for all NIH conference grant applications, including new, resubmission, renewal, and revision applications. Cover letters for a new application cannot be recycled for a resubmission or revision; rather a new letter is required.

Advance permission to submit an application should be requested early in the process and no later than six weeks before the application due date. All applicants must include the permission-to-submit letter from the NIH Conference Grant Contact who has agreed to accept assignment of the application. Applications that do not include the permission-to-submit letter will not be accepted for review.

Note that advance permission to submit an application does not guarantee funding. UPDATE For applications submitted for due dates on or after April 12, 2026: Advance permission to submit an application is no longer required and must not be provided in the Cover Letter attachment. All other instructions in the How to Apply - Application Guide must be followed.

SF424(R&R) Project/Performance Site Locations All instructions in the How to Apply - Application Guide must be followed. SF424(R&R) Other Project Information All instructions in the How to Apply - Application Guide must be followed. SF424(R&R) Senior/Key Person Profile All instructions in the How to Apply - Application Guide must be followed.

All Instructions in the How to Apply - Application Guide must be followed with the following additional instructions. The appropriate NIH IC conference award contact should be consulted for guidance regarding any IC-specific budget requirements. Enter the direct costs requested.

Factilites and Administrative (F&A) costs are not allowed. Provide a narrative justification for each proposed personnel position, including the role of the individual in the conference and the proposed level of effort. Include information regarding efforts to obtain funding for this conference from other sources.

Allowable Costs: Salary (in proportion to the time or effort spent directly on the conference); rental of necessary equipment; travel and per diem or subsistence allowances; supplies needed for conduct of the conference (only if received for use during the budget period); conference services; publication costs; funds to help defray registration costs for some select attendees or speakers' fees.

Non-allowable costs : Meals/food and beverages; purchase of equipment; transportation costs exceeding U.S. carrier coach class fares; visas; passports; entertainment and personal expenses (such as tips; bar charges; personal telephone calls; laundry charges) dues; honoraria or other payments for the purpose of conferring distinction or communicating respect, esteem or admiration; patient care; alterations or renovations; local participants' expenses; facilities and administrative costs/indirect costs.

All instructions in the SF424 (R&R) Application Guide must be followed with the following additional instructions. The appropriate NIH IC conference award contact should be consulted for guidance regarding any IC-specific budget requirements. Enter the direct costs requested.

Facilities and Administrative (F&A) costs are not allowed. Provide a narrative justification for each proposed personnel position, including the role of the individual in the conference and the proposed level of effort. Include information regarding efforts to obtain funding for this conference from other sources.

Allowable Costs: Salary (in proportion to the time or effort spent directly on the conference); rental of necessary equipment; travel and per diem or subsistence allowances; supplies needed for conduct of the conference (only if received for use during the budget period); conference services; publication costs; funds to help defray registration costs for some select attendees or speakers' fees.

Non-allowable costs : Meals/food and beverages; purchase of equipment; transportation costs exceeding U.S. carrier coach class fares; visas; passports; entertainment and personal expenses (such as tips; bar charges; personal telephone calls; laundry charges) dues; honoraria or other payments for the purpose of conferring distinction or communicating respect, esteem or admiration; patient care; alterations or renovations; local participants' expenses; facilities and administrative costs/indirect costs.

All instructions in the How to Apply - Application Guide must be followed. PHS 398 Cover Page Supplement All instructions in the How to Apply - Application Guide must be followed. All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions: Research Strategy : Note that this section will be called "Conference Plan" in the system-generated Table of Contents.

Describe the objectives, specific program, and logistical arrangements for the conference. Describe the format and list the agenda and speakers, including the principal topics to be covered, problems to be addressed, and developments or contributions the conference might stimulate. Provide a detailed justification for the conference, including the scientific need, timeliness, and usefulness of the conference to the scientific community.

Attendance for some individuals will be dependent on the availability of resources for family care. The application should describe plans to identify resources for childcare and other types of family care at or in close proximity to the conference site to allow individuals with family care responsibilities to attend. The information should allow attendees to make arrangements for family care as needed.

Describe the composition (relevant to the scientific mission) and role of the organizing committee, and provide the names and credentials of key participants (i.e. speakers, presenters, session moderators) in the conference, including the basis for their selection.

Estimate anticipated geographic conference area where participants will come from (i.e., national, statewide), the expected size and composition of the audience, as well as the method of selection. Describe plans for publicizing the conference to all interested participants and, if applicable, for publishing the proceedings (note that publishing proceedings is not required).

Identify related conferences held on the subject during the past 3 years and how the proposed conference is similar to and/or different from these, and why it is still necessary and useful. If this is one in a series of periodic conferences held by a permanent sponsoring organization, briefly describe and evaluate the last conference in the series.

Applications requesting multiple years of support must provide the following additional information for each future year requested, in as much detail as possible: Tentative dates, locations, and participants Contingency plans for future conferences dependent upon, for example, the outcome of the first year's conference or developments in the field.

Letters of Support : Provide letters documenting the participation of the key conference participants, e.g. speakers, presenters, session moderators. Resource Sharing Plan : Individuals are required to comply with the instructions for the Resource Sharing Plans as provided in the How to Apply - Application Guide .

All instructions in the How to Apply - Application Guide must be followed, with the following additional instructions: A Data Management and Sharing Plan is not applicable for this NOFO. Appendix: Only limited Appendix materials are allowed. Follow all instructions for the Appendix as described in the How to Apply - Application Guide .

No publications or other material, with the exception of blank questionnaires or blank surveys, may be included in the Appendix.

PHS Human Subjects and Clinical Trials Information When involving human subjects research, clinical research, and/or NIH-defined clinical trials (and when applicable, clinical trials research experience) follow all instructions for the PHS Human Subjects and Clinical Trials Information form in the How to Apply - Application Guide , with the following additional instructions: If you answered “Yes” to the question “Are Human Subjects Involved?

” on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record. Study Record: PHS Human Subjects and Clinical Trials Information All instructions in the How to Apply - Application Guide must be followed.

Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start). All instructions in the How to Apply - Application Guide must be followed. PHS Assignment Request Form All instructions in the How to Apply - Application Guide must be followed.

3. Unique Entity Identifier and System for Award Management (SAM) See Part 2. Section III.

1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants. gov 4. Submission Dates and Times Part I.

contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next business day.

Organizations must submit applications to Grants. gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons , NIH’s electronic system for grants administration.

NIH and Grants. gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.

gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Grants Policy Statement Section 2.

3. 9. 2 Electronically Submitted Applications .

Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission. Information on the submission process and a definition of on-time submission are provided in the How to Apply – Application Guide . 5.

Intergovernmental Review (E. O. 12372) This initiative is not subject to intergovernmental review.

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement . Pre-award costs are allowable only as described in the NIH Grants Policy Statement Section 7. 9.

1 Selected Items of Cost . 7. Other Submission Requirements and Information Applications must be submitted electronically following the instructions described in the How to Apply - Application Guide .

Paper applications will not be accepted. Applicants must complete all required registrations before the application due date. Section III.

Eligibility Information contains information about registration. For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply – Application Guide . If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance.

For assistance with application submission, contact the